These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 6151320

  • 21. [Drug therapy of tachycardial arrhythmias].
    Kaufmann G.
    Schweiz Med Wochenschr; 1976 May 01; 106(18):607-12. PubMed ID: 996478
    [Abstract] [Full Text] [Related]

  • 22. [Drug treatment of a trial fibrillation in patients with Wolff-Parkinson-White syndrome].
    Guaragna RF, Capucci A, Sangiorgio P, Bracchetti D.
    G Ital Cardiol; 1982 May 01; 12(4):284-91. PubMed ID: 6130024
    [Abstract] [Full Text] [Related]

  • 23. [How and why treat supraventricular tachycardias].
    Kulbertus H.
    G Ital Cardiol; 1984 Apr 01; 14(4):269-72. PubMed ID: 6735019
    [Abstract] [Full Text] [Related]

  • 24. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 01; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
    Follath F, Candinas R, Frielingsdorf J.
    Herz; 1993 Feb 14; 18(1):20-6. PubMed ID: 8454249
    [Abstract] [Full Text] [Related]

  • 30. [Drug therapy of pre-excitation syndromes].
    Puletti M, Curione M.
    G Ital Cardiol; 1977 Aug 14; 7(8):809-15. PubMed ID: 21121
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome].
    Neumann G, Grube E, Funke H.
    Herz; 1983 Jun 14; 8(3):153-64. PubMed ID: 6873862
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J, Pfeiffer D, Schumacher B, Korte T, Jung W, Lüderitz B.
    Z Kardiol; 1996 Jun 14; 85 Suppl 6():191-9. PubMed ID: 9064965
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N, Papadopoulos N, Papanastasiou S, Kozirakis M, Maligkos G, Tsaritsaniotis E, Katsaris G.
    Pacing Clin Electrophysiol; 2005 Sep 14; 28(9):954-61. PubMed ID: 16176535
    [Abstract] [Full Text] [Related]

  • 39. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M.
    Kardiol Pol; 2008 Nov 14; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [Abstract] [Full Text] [Related]

  • 40. [Supraventricular tachycardias: mechanism, diagnosis and therapy].
    Osswald S, Buser PT, Rickenbacher P, Pfisterer M.
    Schweiz Med Wochenschr; 1996 Jun 01; 126(22):974-85. PubMed ID: 8693318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.